Cancer Research · 2006 · 93 citations · 29 references
MedicineCancer BiologyOncologyCell SignalingMetastasisSignal TransductionCancer Cell SignalingCancer ProgressionMetastatic Breast CancerMetastatic Signaling PathwaysSignal Transduction In CancerCancer Metastasis MechanismsCell InvasionCellular ChemotaxisChemotactic InvasionChemotaxisErbb Receptor SignalingInvasion-metastasis CascadeMetastasis Promotion
A better understanding of how epidermal growth factor receptor family members (ErbBs) contribute to metastasis is important for evaluating ErbB-directed therapies. Activation of ErbB3/ErbB2 heterodimers can affect both proliferation and motility. We find that increasing ErbB3-dependent signaling in orthotopic injection models of breast cancer can enhance intravasation and lung metastasis with no effect on primary tumor growth or microvessel density. Enhanced metastatic ability due to increased expression of ErbB2 or ErbB3 correlated with stronger chemotaxis and invasion responses to heregulin beta1. Suppression of ErbB3 expression reduced both intravasation and metastasis. A human breast cancer tumor tissue microarray showed a significant association between ErbB3 and ErbB2 expression and metastasis independent of tumor size. These results indicate that ErbB3-dependent signaling through ErbB3/ErbB2 heterodimers can contribute to metastasis through enhancing tumor cell invasion and intravasation in vivo and that ErbB-directed therapies may be useful for the inhibition of invasion independent of effects on tumor growth.
29
Dennis J. Slamon, Gary M. Clark, Steven Wong et al. · Science · 1987 · 11.7K citations
FAK–Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly
Donna J. Webb, Karen Donais, Leanna Whitmore et al. · Nature Cell Biology · 2004 · 1.4K citations
Thomas Holbro, Roger R. Beerli, Francisca Maurer et al. · Proceedings of the National Academy of Sciences · 2003 · 960 citations · Full text